valproic acid has been researched along with Anosmia in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Anosmia: Complete or severe loss of the subjective sense of smell. Loss of smell may be caused by many factors such as a cold, allergy, OLFACTORY NERVE DISEASES, viral RESPIRATORY TRACT INFECTIONS (e.g., COVID-19), aging and various neurological disorders (e.g., ALZHEIMER DISEASE).
Excerpt | Relevance | Reference |
---|---|---|
"Valproic acid (VPA) has been widely used for the treatment of epilepsy." | 3.30 | Therapeutic Potential of Valproic Acid for Postviral Olfactory Dysfunction: A Single-Arm Pilot Study. ( Hira, D; Kikuoka, H; Matsumoto, K; Ogawa, T; Shimizu, T; Tojima, I, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ogawa, T | 1 |
Matsumoto, K | 1 |
Tojima, I | 1 |
Kikuoka, H | 1 |
Hira, D | 1 |
Shimizu, T | 1 |
1 trial available for valproic acid and Anosmia
Article | Year |
---|---|
Therapeutic Potential of Valproic Acid for Postviral Olfactory Dysfunction: A Single-Arm Pilot Study.
Topics: Animals; Anosmia; Olfaction Disorders; Pilot Projects; Smell; Valproic Acid | 2023 |